Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species
AUTOR(ES)
Parra-Ortega, B, Cruz-Torres, H, Villa-Tanaca, L, Hernández-Rodríguez, C
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2009-05
RESUMO
Aspartyl proteases are a class of enzymes that include the yeast aspartyl proteases and secreted aspartyl protease (Sap) superfamilies. Several Sap superfamily members have been demonstrated or suggested as virulence factors in opportunistic pathogens of the genus Candida. Candida albicans, Candida tropicalis, Candida dubliniensis and Candida parapsilosis harbour 10, four, eight and three SAP genes, respectively. In this work, genome mining and phylogenetic analyses revealed the presence of new members of the Sap superfamily in C. tropicalis (8), Candida guilliermondii (8), C. parapsilosis(11) and Candida lusitaniae (3). A total of 12 Sap families, containing proteins with at least 50% similarity, were discovered in opportunistic, pathogenic Candida spp. In several Sap families, at least two subfamilies or orthologous groups were identified, each defined by > 90% sequence similitude, functional similarity and synteny among its members. No new members of previously described Sap families were found in a Candida spp. clinical strain collection; however, the universality of SAPT gene distribution among C. tropicalis strains was demonstrated. In addition, several features of opportunistic pathogenic Candida species, such as gene duplications and inversions, similitude, synteny, putative transcription factor binding sites and genome traits of SAP gene superfamily were described in a molecular evolutionary context.
Documentos Relacionados
- Phylogeny and Evolution of Medical Species of Candida and Related Taxa: a Multigenic Analysis
- Identification of clinically relevant viridans group streptococci to the species level by PCR.
- Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.
- Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.
- Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species